Lansoprazole Capsule, Delayed Release
Product Images NDC 71335-2957

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 71335-2957). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

A line graph depicting the mean severity of day heartburn over time for evaluable patients. The severity scale ranges from 0 (none) to 3 (severe). The x-axis represents days from the start of treatment, spanning approximately 60 days. Data is shown for placebo and lansoprazole at 15 mg and 30 mg doses, illustrating changes in heartburn severity during the study period.*

FDA Label Image

Figure2 (Figure2)

A line graph showing mean severity of night heartburn by study day for evaluable patients over 60 days. The graph compares placebo, lansoprazole 15 mg once daily, and lansoprazole 30 mg once daily, with severity ratings from 0 (none) to 3 (severe).*

FDA Label Image

Label (Lbl713352957)

Lansoprazole Delayed-Release Capsules USP 15 mg packaging label showing a 30 count bottle. The label includes the NDC 71335-2957-1, repackaged by Bryant Ranch Prepack, and manufactured by Dr. Reddys Laboratories Ltd. It states the capsules are oral delayed-release with instructions to store at 20-25°C and keep out of reach of children.*

FDA Label Image

Structure (Structure)

Chemical structure of lansoprazole, showing its molecular components including a benzimidazole ring, sulfoxide functional group, and substituted pyridine ring with trifluoromethoxy group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.